Sweet Syndrome Can Be Clue of Leprosy : A Case Report

Authors

  • Piyaphak Saengthongpini Department of Medicine, Chonburi Hospital

Keywords:

Leprosy, Leprosy reaction, type 2 reaction, Sweet syndrome

Abstract

Leprosy is a chronic infectious disease caused by Mycobacterium leprae. It is an uncommon disease nowadays. Sometimes, type 2 lepra reaction or erythema nodosum leprosum is the first manifestation before diagnosis of leprosy. Type 2 lepra reaction represents as immune complex mediated disease causing inflammation in all tissue. Common manifestations include erythematous painful ulcer-prone nodules and neuritis which can cause permanent disability if delay diagnosis.  Herein, we report a case of leprosy with type 2 reaction which resemble Sweet syndrome. Sweet syndrome is frequently triggered by bacterial infection. Leprosy is an uncommon cause of Sweet syndrome, so it may be overlooked and delayed treatment.

Leprosy should be considered in the differential diagnosis of Sweet syndrome. Early diagnosis reduces disease spreading and permanent disability.

Author Biography

Piyaphak Saengthongpini, Department of Medicine, Chonburi Hospital

Dermatologist Unit

References

กลุ่มควบคุมโรคเรื้อน สถาบันราชประชาสมาสัย.สถานการณ์โรคเรื้อนในประเทศไทย ปี พ.ศ.2562 [อินเทอร์เน็ต]. 2563 [เข้าถึงเมื่อ 8 ธันวาคม 2563]. เข้าถึงได้จาก: http://thaileprosy.ddc.moph.go.th/site/index.htm

สถาบันราชประชาสมาสัย กรมควบคุมโรค. คู่มือวินิจฉัยและรักษาโรคเรื้อน. พิมพ์ครั้งที่ 7. กรุงเทพฯ: โรงพิมพ์สำนักงานพระพุทธศาสนาแห่งชาติ; 2553.

Walker SL, Lockwood DN. Leprosy. Clin Dermatol 2007; 25(2):165-72.

Kamath S, Vaccaro SA, Rea TH, Ochoa MT. Recog-nizing and managing the immunologic reactions in leprosy. J Am Acad Dermatol 2014;71(4):795-803.

Skold A, Cosco DL, Klein R. Methemoglobinemia: pathogenesis, diagnosis, and management. South Med 2011;104(11):757-61.

Ezhilarasan D. Dapsone-induced hepatic complica-tions: it’s time to think beyond methemoglobinemia.Drug and Chemical Toxicology 2019:44(2):1-4.

Villarreal-Villarreal CD, Ocampo-Candiani J, Villar-real-Martinez A. Sweet syndrome: a review and update. Actas Dermosifiliogr 2016;107(5):369-78.

Giasuddin AS, El-Orfi AH, Ziu MM, El-Barnawi NY. Sweet’s syndrome: is the pathogenesis mediated by helper T cell type 1 cytokines. J Am Acad Dermatol 1998;39(6):940-3.

Lee DJ, Li H, Ochoa MT, Tanaka M, Carbone RJ, Damoiseaux R, et al. Integrated pathways for neutrophil recruitment and inflammation in leprosy. J Infect Dis 2010;201(4):558-69.

Rochet NM, Chavan RN, Cappel MA, Wada DA, Gibson LE. Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol 2013;69(4):557-64.

Chavez-Alvarez S, Herz-Ruelas M, Ocampo-Can-diani J, Gomez-Flores M. Type 2 leprosy re-action resembling sweet syndrome: review of new and published cases. Australas J Dermatol 2020;61(2):e234-7.

Downloads

Published

2022-08-31 — Updated on 2026-02-04

Versions